Scienture Holdings Net Income Over Time
| SCNX Stock | 0.46 0.01 2.13% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Scienture Holdings Performance and Scienture Holdings Correlation. Scienture | Build AI portfolio with Scienture Stock |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scienture Holdings. If investors know Scienture will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Scienture Holdings assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 0.75 | Revenue Per Share | Quarterly Revenue Growth 8.097 | Return On Assets | Return On Equity |
Understanding Scienture Holdings requires distinguishing between market price and book value, where the latter reflects Scienture's accounting equity. The concept of intrinsic value - what Scienture Holdings' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Scienture Holdings' price substantially above or below its fundamental value.
Please note, there is a significant difference between Scienture Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scienture Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Scienture Holdings' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Scienture Holdings and related stocks such as Bullfrog AI Holdings, Tenon Medical, and Sensei Biotherapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BFRG | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (341.7 K) | (585.8 K) | (2.8 M) | (5.4 M) | (7 M) | (6.3 M) | (6 M) |
| TNON | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (585.2 K) | (7 M) | (18.9 M) | (15.6 M) | (13.7 M) | (12.3 M) | (12.9 M) |
| SNSE | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (13 M) | (16.7 M) | (20.1 M) | (36.8 M) | (48.8 M) | (34.1 M) | (30.2 M) | (27.1 M) | (28.5 M) |
| EVGN | 645 K | 645 K | (2.5 M) | (8.9 M) | (14.5 M) | (17.2 M) | (19.6 M) | (20.8 M) | (20.8 M) | (18.1 M) | (23.4 M) | (27.8 M) | (26.6 M) | (23.9 M) | (16.5 M) | (14.8 M) | (15.6 M) |
| TRAW | (30.3 M) | (30.3 M) | (33.9 M) | (64.9 M) | (63.7 M) | (24 M) | (19.7 M) | (24.1 M) | (20.6 M) | (21.5 M) | (25.2 M) | (16.2 M) | (19 M) | (18.9 M) | (54.7 M) | (62.9 M) | (66 M) |
| IMNN | (1.9 M) | (23.2 M) | (26.6 M) | (8.3 M) | (25.5 M) | (22.5 M) | (22.1 M) | (20.4 M) | (11.9 M) | (16.9 M) | (21.5 M) | (20.8 M) | (35.9 M) | (19.5 M) | (18.6 M) | (16.8 M) | (17.6 M) |
| BOLT | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (30.5 M) | (60.7 M) | (98.6 M) | (88.1 M) | (69.2 M) | (63.1 M) | (56.8 M) | (59.6 M) |
| AEON | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | 172.9 M | (32.9 M) | (55.6 M) | (52.6 M) | (384.6 M) | 42 M | 37.8 M | 39.7 M |
| XAIR | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (4.8 M) | (3.7 M) | (29.7 K) | (18 M) | (6.6 M) | (19.9 M) | (22.9 M) | (43.2 M) | (55.8 M) | (60.2 M) | (46.6 M) | (42 M) | (39.9 M) |
| CING | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (11.5 M) | (7.2 M) | (20.7 M) | (17.9 M) | (23.5 M) | (15.5 M) | (14 M) | (14.7 M) |
Scienture Holdings and related stocks such as Bullfrog AI Holdings, Tenon Medical, and Sensei Biotherapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Scienture Holdings financial statement analysis. It represents the amount of money remaining after all of Scienture Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Scienture Holdings | SCNX |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 6308 Benjamin Rd, |
| Exchange | NASDAQ Exchange |
null 0.46
Additional Tools for Scienture Stock Analysis
When running Scienture Holdings' price analysis, check to measure Scienture Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scienture Holdings is operating at the current time. Most of Scienture Holdings' value examination focuses on studying past and present price action to predict the probability of Scienture Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scienture Holdings' price. Additionally, you may evaluate how the addition of Scienture Holdings to your portfolios can decrease your overall portfolio volatility.